Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@drsprs Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::182541217.png) @drsprs Dr. S

Dr. S posts on X about $cere, $krtx, $etnb, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::182541217/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::182541217/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXXX +440%
- X Months XXXXXX -XX%
- X Year XXXXXXX +202%

### Mentions: X [#](/creator/twitter::182541217/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::182541217/c:line/m:posts_active.svg)

- X Week XX no change
- X Month XX +90%
- X Months XX -XX%
- X Year XXX +22%

### Followers: XXXXX [#](/creator/twitter::182541217/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::182541217/c:line/m:followers.svg)

- X Week XXXXX +1.20%
- X Month XXXXX +5.70%
- X Months XXXXX +20%
- X Year XXXXX +53%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::182541217/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::182541217/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::182541217/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX% [social networks](/list/social-networks)  XXXX% [technology brands](/list/technology-brands)  XXXX% [stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[$cere](/topic/$cere) #2, [$krtx](/topic/$krtx) #2, [$etnb](/topic/$etnb) #3, [discount](/topic/discount) #2233, [$gral](/topic/$gral) 1.79%, [imo](/topic/imo) 1.79%, [$tdoc](/topic/$tdoc) 1.79%, [$dkng](/topic/$dkng) 1.79%, [twitter](/topic/twitter) 1.79%, [contra](/topic/contra) XXXX%

**Top accounts mentioned or mentioned by**
[@notjanetyellen7](/creator/undefined) [@valuedig](/creator/undefined) [@bronxb_13](/creator/undefined) [@knightcharo](/creator/undefined) [@bronxb13](/creator/undefined) [@msollender](/creator/undefined) [@goderguy](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@west0_cap](/creator/undefined) [@dancingtapas](/creator/undefined) [@markland55](/creator/undefined) [@avidresearch](/creator/undefined) [@askbio](/creator/undefined) [@monacobiotech](/creator/undefined) [@wexcapital](/creator/undefined) [@andersresearch](/creator/undefined) [@susanbenali](/creator/undefined) [@miamkitty](/creator/undefined) [@jlvle](/creator/undefined) [@michellefdavis](/creator/undefined)

**Top assets mentioned**
[Cere Network (CERE)](/topic/$cere) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [GRAIL, Inc. Common Stock (GRAL)](/topic/$gral) [Teladoc Health, Inc. (TDOC)](/topic/$tdoc) [DraftKings Inc. Class A Common Stock (DKNG)](/topic/$dkng) [Sea Limited (SE)](/topic/$se) [Snap, Inc. (SNAP)](/topic/$snap) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Club Atletico Independiente Fan Token (CAI)](/topic/$cai)
### Top Social Posts [#](/creator/twitter::182541217/posts)
---
Top posts by engagements in the last XX hours

"Some cash burning shitcos should raise capital if possible with this trash rally. Example $GRAL why did it 3X from April. Any other come to mind"  
[X Link](https://x.com/drsprs/status/1974156399178657928) [@drsprs](/creator/x/drsprs) 2025-10-03T16:55Z 2182 followers, 3936 engagements


"This is an identical situation to $CERE v. $KRTX a few years back. This is essentially a time arbitrage with binary risk. $ETNB drug "probably" works like XX% chance imo but you have to wait for the readout. So the stock price currently reflects that discount. If a pharma wants to take a chance and get a discount they probably could buy them out for $XX a share I bet BOD would take it. However there is a real binary risk for a pharma later on it didn't work out well for Cerevel and Abbvie so far"  
[X Link](https://x.com/drsprs/status/1884705797739078080) [@drsprs](/creator/x/drsprs) 2025-01-29T20:50Z 2184 followers, 6502 engagements


"Wow I was close thought $XX buy out. $XXXXX + $X CVR = $XXXXX total potentially. #biosquidgames pick $ETNB"  
[X Link](https://x.com/drsprs/status/1968552276932304958) [@drsprs](/creator/x/drsprs) 2025-09-18T05:46Z 2182 followers, 4917 engagements


"Are you having trouble sorting out the markets Here are X great contras on Twitter. Back tested and extremely reverse accurate. 👇 Not trying to be mean just truthful my wife is my best trading contra she just doesn't know it. 😂 $TDOC $SE $SNAP $DKNG"  
[X Link](https://x.com/drsprs/status/1618839776408510469) [@drsprs](/creator/x/drsprs) 2023-01-27T05:14Z 2184 followers, 1497 engagements


"@JlVlE @NotJanetYellen7 RGEN DHR DIM"  
[X Link](https://x.com/drsprs/status/1974296918164693407) [@drsprs](/creator/x/drsprs) 2025-10-04T02:14Z 2176 followers, XXX engagements


"$MXCT $CLPT are "toll collectors." At first glance they are attractive since they avoid direct program risk but overall they extract a very small portion of the overall revenue per pt. So they need to have multiple killer apps (commercial) to be scalable + profitable long term. Casgevy is not it. It's clearly not so far. But Maxcyte does have tons of clinical progs in the works do any look like commercial blockbusters $CLPT looks they have X potentially in AMT-130 by $QURE. But look at the financials base case 1000 pts/yr. Uniqure gets 2Mx1000=2B. Clearpoint gets 20Kx1000=20M. Underwhelming."  
[X Link](https://x.com/drsprs/status/1974531283817767270) [@drsprs](/creator/x/drsprs) 2025-10-04T17:45Z 2184 followers, 3128 engagements


"For all the chatter that Europe is an aging relic with no innovation European biotechs the past X years have made huge impacts on standard of care in medicine. Argenx $ARGX âž¡ any IVIG indication Ascendis $ASND âž¡ hypoparathyroidism Abivax $ABVX âž¡ effective oral option for UC Adaptimmune $ADAP âž¡ synovial sarcoma Immunocore $IMCR âž¡ uveal melanoma Merus $MRUS âž¡ head and neck cancer and possibly colorectal cancer Uniqure $QURE âž¡ Huntington's disease Practice changing medications probably people need to rethink their opinion on European biotech"  
[X Link](https://x.com/drsprs/status/1970878114600501441) [@drsprs](/creator/x/drsprs) 2025-09-24T15:48Z 2184 followers, 10.5K engagements


"$CAI first Q as public co looks totally different from their private years. Gross margin went from 30s to 60s ASP up 50+% and test volume up XX% (vol is believable). Is this real and/or sustainable Any opinions"  
[X Link](https://x.com/drsprs/status/1955683249352741009) [@drsprs](/creator/x/drsprs) 2025-08-13T17:29Z 2160 followers, 2421 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@drsprs Avatar @drsprs Dr. S

Dr. S posts on X about $cere, $krtx, $etnb, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXX -XX%
  • X Month XXXXXX +440%
  • X Months XXXXXX -XX%
  • X Year XXXXXXX +202%

Mentions: X #

Mentions Line Chart

  • X Week XX no change
  • X Month XX +90%
  • X Months XX -XX%
  • X Year XXX +22%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +1.20%
  • X Month XXXXX +5.70%
  • X Months XXXXX +20%
  • X Year XXXXX +53%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence cryptocurrencies XXXX% social networks XXXX% technology brands XXXX% stocks XXXX% finance XXXX%

Social topic influence $cere #2, $krtx #2, $etnb #3, discount #2233, $gral 1.79%, imo 1.79%, $tdoc 1.79%, $dkng 1.79%, twitter 1.79%, contra XXXX%

Top accounts mentioned or mentioned by @notjanetyellen7 @valuedig @bronxb_13 @knightcharo @bronxb13 @msollender @goderguy @aaronrosenblum5 @west0_cap @dancingtapas @markland55 @avidresearch @askbio @monacobiotech @wexcapital @andersresearch @susanbenali @miamkitty @jlvle @michellefdavis

Top assets mentioned Cere Network (CERE) Karuna Therapeutics, Inc. Common Stock (KRTX) GRAIL, Inc. Common Stock (GRAL) Teladoc Health, Inc. (TDOC) DraftKings Inc. Class A Common Stock (DKNG) Sea Limited (SE) Snap, Inc. (SNAP) Merus N.V. Common Shares (MRUS) Club Atletico Independiente Fan Token (CAI)

Top Social Posts #


Top posts by engagements in the last XX hours

"Some cash burning shitcos should raise capital if possible with this trash rally. Example $GRAL why did it 3X from April. Any other come to mind"
X Link @drsprs 2025-10-03T16:55Z 2182 followers, 3936 engagements

"This is an identical situation to $CERE v. $KRTX a few years back. This is essentially a time arbitrage with binary risk. $ETNB drug "probably" works like XX% chance imo but you have to wait for the readout. So the stock price currently reflects that discount. If a pharma wants to take a chance and get a discount they probably could buy them out for $XX a share I bet BOD would take it. However there is a real binary risk for a pharma later on it didn't work out well for Cerevel and Abbvie so far"
X Link @drsprs 2025-01-29T20:50Z 2184 followers, 6502 engagements

"Wow I was close thought $XX buy out. $XXXXX + $X CVR = $XXXXX total potentially. #biosquidgames pick $ETNB"
X Link @drsprs 2025-09-18T05:46Z 2182 followers, 4917 engagements

"Are you having trouble sorting out the markets Here are X great contras on Twitter. Back tested and extremely reverse accurate. 👇 Not trying to be mean just truthful my wife is my best trading contra she just doesn't know it. 😂 $TDOC $SE $SNAP $DKNG"
X Link @drsprs 2023-01-27T05:14Z 2184 followers, 1497 engagements

"@JlVlE @NotJanetYellen7 RGEN DHR DIM"
X Link @drsprs 2025-10-04T02:14Z 2176 followers, XXX engagements

"$MXCT $CLPT are "toll collectors." At first glance they are attractive since they avoid direct program risk but overall they extract a very small portion of the overall revenue per pt. So they need to have multiple killer apps (commercial) to be scalable + profitable long term. Casgevy is not it. It's clearly not so far. But Maxcyte does have tons of clinical progs in the works do any look like commercial blockbusters $CLPT looks they have X potentially in AMT-130 by $QURE. But look at the financials base case 1000 pts/yr. Uniqure gets 2Mx1000=2B. Clearpoint gets 20Kx1000=20M. Underwhelming."
X Link @drsprs 2025-10-04T17:45Z 2184 followers, 3128 engagements

"For all the chatter that Europe is an aging relic with no innovation European biotechs the past X years have made huge impacts on standard of care in medicine. Argenx $ARGX âž¡ any IVIG indication Ascendis $ASND âž¡ hypoparathyroidism Abivax $ABVX âž¡ effective oral option for UC Adaptimmune $ADAP âž¡ synovial sarcoma Immunocore $IMCR âž¡ uveal melanoma Merus $MRUS âž¡ head and neck cancer and possibly colorectal cancer Uniqure $QURE âž¡ Huntington's disease Practice changing medications probably people need to rethink their opinion on European biotech"
X Link @drsprs 2025-09-24T15:48Z 2184 followers, 10.5K engagements

"$CAI first Q as public co looks totally different from their private years. Gross margin went from 30s to 60s ASP up 50+% and test volume up XX% (vol is believable). Is this real and/or sustainable Any opinions"
X Link @drsprs 2025-08-13T17:29Z 2160 followers, 2421 engagements

@drsprs
/creator/twitter::drsprs